[go: up one dir, main page]

AU3644089A - Chroman derivatives - Google Patents

Chroman derivatives

Info

Publication number
AU3644089A
AU3644089A AU36440/89A AU3644089A AU3644089A AU 3644089 A AU3644089 A AU 3644089A AU 36440/89 A AU36440/89 A AU 36440/89A AU 3644089 A AU3644089 A AU 3644089A AU 3644089 A AU3644089 A AU 3644089A
Authority
AU
Australia
Prior art keywords
chroman derivatives
chroman
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU36440/89A
Other versions
AU626549B2 (en
Inventor
Manfred Dr. Baumgarth
Rolf Dr. Bergmann
Jacques Dr. De Peyer
Rolf Dr. Gericke
Prof. Dr. Gunther Hausler
Ingeborg Dr. Lues
Hanns Dr. Wurziger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE3820506A external-priority patent/DE3820506A1/en
Priority claimed from DE3835011A external-priority patent/DE3835011A1/en
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of AU3644089A publication Critical patent/AU3644089A/en
Application granted granted Critical
Publication of AU626549B2 publication Critical patent/AU626549B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AU36440/89A 1988-06-16 1989-06-14 Chroman derivatives Ceased AU626549B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3820506 1988-06-16
DE3820506A DE3820506A1 (en) 1988-06-16 1988-06-16 N-Heterocyclically substituted chroman derivatives and their use as medicaments
DE3835011 1988-10-14
DE3835011A DE3835011A1 (en) 1988-10-14 1988-10-14 CHROME DERIVATIVES

Publications (2)

Publication Number Publication Date
AU3644089A true AU3644089A (en) 1989-12-21
AU626549B2 AU626549B2 (en) 1992-08-06

Family

ID=25869185

Family Applications (1)

Application Number Title Priority Date Filing Date
AU36440/89A Ceased AU626549B2 (en) 1988-06-16 1989-06-14 Chroman derivatives

Country Status (11)

Country Link
EP (1) EP0346724A1 (en)
JP (1) JPH0240375A (en)
KR (1) KR910000711A (en)
AU (1) AU626549B2 (en)
DK (1) DK296789A (en)
FI (1) FI92824C (en)
HU (1) HUT56096A (en)
IL (1) IL90613A0 (en)
NO (1) NO174391C (en)
NZ (1) NZ229540A (en)
PT (1) PT90864B (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU619766B2 (en) * 1987-10-12 1992-02-06 Sanofi 2,2-dimethylchromene derivatives, process for their preparation and pharmaceutical compositions in which they are present
AU623780B2 (en) * 1989-06-02 1992-05-21 Merck Patent Gesellschaft Mit Beschrankter Haftung Chromanderivate
AU628331B2 (en) * 1988-05-06 1992-09-17 Merck Patent Gesellschaft Mit Beschrankter Haftung Chroman derivatives
AU628395B2 (en) * 1988-10-14 1992-09-17 Merck Patent Gesellschaft Mit Beschrankter Haftung Chroman derivatives
AU633383B2 (en) * 1989-11-29 1993-01-28 Beecham Group Plc A process for the preparation of chiral 3,4-epoxybenzopyrans
AU674940B2 (en) * 1993-03-10 1997-01-16 Pfizer Research And Development Company, N.V./S.A. Benzopyranes as potassium channel openers

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8924376D0 (en) * 1989-10-30 1989-12-20 Beecham Group Plc Novel compounds
JP2575226B2 (en) * 1990-05-11 1997-01-22 吉富製薬株式会社 Process for producing optically active 3,4-dihydro-3,4-epoxy-2H-1 benzopyran compound and synthetic intermediate thereof
CA2070243A1 (en) * 1991-06-14 1992-12-15 Akira Shiozawa Chroman derivatives
RU2104277C1 (en) * 1992-11-25 1998-02-10 Сандос Лтд. 2,2-dialkyl or trans-2,2-dialkyl-3,4-dihydro-3-hydroxy-6- (pyridin-4-yl)-2h-1-benzopyrans
WO1994012493A1 (en) * 1992-11-25 1994-06-09 Sandoz, Ltd. 2,2-dialkyl- and 2,2-dialkyl-3,4-dihydro-3-hydroxy-2h-1-benzopyr ans, their use as pharmaceuticals
AU665040B2 (en) * 1992-11-25 1995-12-14 Novartis Ag 4-carboxamido-6(pyridin-4-yl substituted benzopyran derivatives
GB9316111D0 (en) * 1993-08-04 1993-09-22 Pfizer Ltd Benzopyrans
US5574049A (en) * 1994-07-22 1996-11-12 Sandoz Ltd. 2,2-dialkyl- and 2,2-dialkyl-3,4-dihydro-3-hydroxy-2H-1-benzopyrans
JP2007000772A (en) * 2005-06-23 2007-01-11 Casio Electronics Co Ltd Double microcapsule, production method thereof, and surface treatment method of microcapsule

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3274350D1 (en) * 1981-09-25 1987-01-08 Beecham Group Plc Pharmaceutically active benzopyran compounds
EP0107423B1 (en) * 1982-10-19 1986-07-23 Beecham Group Plc Novel chromans and chromenes
PT84806B (en) * 1986-05-03 1989-12-29 Beecham Group Plc PROCESS FOR THE PREPARATION OF BENZOPYRANES
DE3726261A1 (en) * 1986-12-23 1988-07-07 Merck Patent Gmbh CHROME DERIVATIVES
CH674984A5 (en) * 1987-05-16 1990-08-15 Sandoz Ag
FR2621587B1 (en) * 1987-10-12 1990-02-09 Sanofi Sa 2,2-DIMETHYL CHROMENE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
AU628331B2 (en) * 1988-05-06 1992-09-17 Merck Patent Gesellschaft Mit Beschrankter Haftung Chroman derivatives

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU619766B2 (en) * 1987-10-12 1992-02-06 Sanofi 2,2-dimethylchromene derivatives, process for their preparation and pharmaceutical compositions in which they are present
AU628331B2 (en) * 1988-05-06 1992-09-17 Merck Patent Gesellschaft Mit Beschrankter Haftung Chroman derivatives
AU628395B2 (en) * 1988-10-14 1992-09-17 Merck Patent Gesellschaft Mit Beschrankter Haftung Chroman derivatives
AU623780B2 (en) * 1989-06-02 1992-05-21 Merck Patent Gesellschaft Mit Beschrankter Haftung Chromanderivate
AU633383B2 (en) * 1989-11-29 1993-01-28 Beecham Group Plc A process for the preparation of chiral 3,4-epoxybenzopyrans
AU674940B2 (en) * 1993-03-10 1997-01-16 Pfizer Research And Development Company, N.V./S.A. Benzopyranes as potassium channel openers

Also Published As

Publication number Publication date
PT90864A (en) 1989-12-29
FI892948A0 (en) 1989-06-15
KR910000711A (en) 1991-01-30
EP0346724A1 (en) 1989-12-20
HUT56096A (en) 1991-07-29
NO174391B (en) 1994-01-17
FI92824C (en) 1995-01-10
PT90864B (en) 1994-11-30
IL90613A0 (en) 1990-01-18
JPH0240375A (en) 1990-02-09
FI892948A7 (en) 1989-12-17
NO174391C (en) 1994-04-27
DK296789D0 (en) 1989-06-15
NO892494L (en) 1989-12-18
FI92824B (en) 1994-09-30
NZ229540A (en) 1991-03-26
NO892494D0 (en) 1989-06-15
AU626549B2 (en) 1992-08-06
DK296789A (en) 1989-12-17

Similar Documents

Publication Publication Date Title
AU8268987A (en) Chroman derivatives
AU1855688A (en) Benzopyran derivatives
AU3390189A (en) Chroman derivatives
AU4764990A (en) 3-Aryl-4-hydroxy-delta3-pyrroline-2-one derivatives
AU636155B2 (en) Thienodiazepine derivatives
AU6799990A (en) 2-iminopyridine derivatives
AU2883989A (en) Avermectin derivatives
AU631896B2 (en) 3-arylurail derivatives
AU3301689A (en) 1-azabicyclo-alkyl derivatives
AU3644089A (en) Chroman derivatives
AU1815392A (en) Chroman derivatives
AU623797B2 (en) Chroman derivatives
AU6670090A (en) Substituted pyrimidobenzimidazole derivatives
AU623544B2 (en) Chroman derivatives
AU4256589A (en) Chroman derivatives
AU2963389A (en) Pyranobenzoxadiazole derivatives
AU1255388A (en) Chromone derivatives
AU6204690A (en) Epiopodophyllotoxin altroside derivatives
AU5911190A (en) 4-phenylpyridonyl chroman derivatives
AU616039B2 (en) Benzopyranol derivatives
AU3315889A (en) Phosphonoalkylpurine derivatives
AU4601389A (en) Novel benzopyranylpyrrolinone derivatives
AU3330789A (en) Arylpropanamine derivatives
AU3156989A (en) Androst-4-ene derivatives
AU3301589A (en) Oxadiazole-1-azabicyclo-alkane derivatives